The latest closing stock price for Alnylam Pharmaceuticals as of April 15, 2025 is 230.93.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $37,424 today, roughly 37 times their original investment - a 18.98% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 31.8% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 141.98, which is 38.5% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 238.79.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $37,424 today, roughly 37 times their original investment - a 18.98% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 31.8% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 141.98, which is 38.5% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 238.79.